Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. [electronic resource]
Producer: 20040914Description: 666-72 p. digitalISSN:- 0007-0920
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biopsy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- ErbB Receptors -- biosynthesis
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy
- Predictive Value of Tests
- Prognosis
- Prospective Studies
- RNA, Messenger -- biosynthesis
- Receptor, ErbB-2 -- biosynthesis
- Reverse Transcriptase Polymerase Chain Reaction
- Sensitivity and Specificity
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.